UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia

Journal of thrombosis and haemostasis, 2017-09, Vol.15 (9), p.1859-1866

2017

Volltextzugriff (PDF)

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion

Cancer medicine (Malden, MA), 2023-08, Vol.12 (16), p.16788-16792

2023

Volltextzugriff (PDF)

Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes

Leukemia, 2013-03, Vol.27 (3), p.610-618

2013

Volltextzugriff (PDF)

Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

Leukemia, 2014-08, Vol.28 (8), p.1747-1750

2014

Volltextzugriff (PDF)

P788: FACTORS DRIVING TREATMENT DECISION IN PATIENTS WITH INTERMEDIATE‐RISK MYELODYSPLASTIC SYNDROME (MDS): A RETROSPECTIVE ANALYSIS FROM THE GRUPO ESPAÑOL DE SÍNDROMES MIELODISPLÁSICOS SPANISH MDS REGISTRY

HemaSphere, 2022-06, Vol.6, p.683-684

2022

Volltextzugriff (PDF)

Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: a 10-year single-centre experience

Internal medicine journal, 2014-06, Vol.44 (6), p.610-612

2014

Volltextzugriff (PDF)

Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients

Leukemia research, 2014-10, Vol.38 (10), p.1199-1206

2014

Volltextzugriff (PDF)

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Leukemia, 2021-03, Vol.35 (3), p.835-849

2021

Volltextzugriff (PDF)

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

Blood cancer journal (New York), 2018-11, Vol.8 (12), p.117-11, Article 117

2018

Volltextzugriff (PDF)

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.684-690

2014

Volltextzugriff (PDF)

Monoclonal free light chains can be found in heavy chain diseases

Annals of clinical biochemistry, 2010-11, Vol.47 (Pt 6), p.570-572

2010

Volltextzugriff (PDF)

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

Leukemia, 2009-04, Vol.23 (4), p.664-672

2009

Volltextzugriff (PDF)

Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (8), p.729-738

2004

Volltextzugriff (PDF)

Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

Blood, 2023-04, Vol.141 (17), p.2047-2061

2023

Volltextzugriff (PDF)

P783: SYSTEMIC THERAPY UTILIZATION AND HEMATOLOGIC OUTCOMES IN LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS): FINDINGS FROM A REAL‐WORLD MEDICAL RECORD REVIEW STUDY IN THE US, UK, AND EUROPE (EU)

HemaSphere, 2022-06, Vol.6, p.678-679

2022

Volltextzugriff (PDF)

Síndromes mielodisplásicos

Medicine - programa de formación médica continuada acreditado, 2016-11, Vol.12 (21), p.1224-1234

2016

Volltextzugriff (PDF)

What is the Outcome of Patients in the Intermediate IPSS-R Score Group? Spanish Approach for Better Stratification with Classical Tools

Leukemia research, 2017-04, Vol.55, p.S150-S151

2017

Volltextzugriff (PDF)

Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

Leukemia research, 2017-04, Vol.55, p.S117-S117

2017

Volltextzugriff (PDF)

P728: GENE EXPRESSION PROFILE REVELS T‐LYMPHOCYTES ACTIVATION THROUGH CELL CYCLE PROGRESSION AND MITOCHONDRIAL METABOLISM REGULATION IN MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) AFTER LENALIDOMIDE TREATMENT

HemaSphere, 2022-06, Vol.6, p.623-624

2022

Volltextzugriff (PDF)

DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia

Leukemia research, 2017-04, Vol.55, p.S100-S100

2017

Volltextzugriff (PDF)

CD34?+ cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation

Leukemia & lymphoma, 2005-02, Vol.46 (2), p.177-183

2005

Volltextzugriff (PDF)

Mutational and Clonal Dynamics During Progression from MDS to SAML by Whole-Exome and Targeted-Deep Sequencing

Leukemia research, 2017-04, Vol.55, p.S55-S55

2017

Volltextzugriff (PDF)

Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

Leukemia research, 2017-04, Vol.55, p.S27-S29

2017

Volltextzugriff (PDF)

Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence

Leukemia research, 2017-04, Vol.55, p.S52-S52

2017

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(198)

Publikationsform

Artikel
(218)
Berichte
(1)

Sprache

Englisch
(218)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(59)
Science & Technology
(59)
Life Sciences & Biomedicine
(57)
Hematology
(43)
Hematology, Oncology And Palliative Medicine
(42)
Male
(39)
Female
(37)
Aged
(32)
Middle Aged
(29)
Adult
(24)
Oncology
(19)
Myelodysplastic Syndrome
(18)
Aged, 80 And Over
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Treatment Outcome
(15)
Myelodysplastic Syndromes
(14)
Myelodysplastic Syndromes - Genetics
(13)
Prognosis
(13)
Retrospective Studies
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion

Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes

Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

P788: FACTORS DRIVING TREATMENT DECISION IN PATIENTS WITH INTERMEDIATE‐RISK MYELODYSPLASTIC SYNDROME (MDS): A RETROSPECTIVE ANALYSIS FROM THE GRUPO ESPAÑOL DE SÍNDROMES MIELODISPLÁSICOS SPANISH MDS REGISTRY

Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: a 10-year single-centre experience

Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

Monoclonal free light chains can be found in heavy chain diseases

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study

Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

P783: SYSTEMIC THERAPY UTILIZATION AND HEMATOLOGIC OUTCOMES IN LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS): FINDINGS FROM A REAL‐WORLD MEDICAL RECORD REVIEW STUDY IN THE US, UK, AND EUROPE (EU)

P756: ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM (MDS/MPN) OVERLAP SYNDROMES. A SINGLE CENTER EXPERIENCE AND DISSECTION OF MUTATIONAL PROFILE

Síndromes mielodisplásicos

What is the Outcome of Patients in the Intermediate IPSS-R Score Group? Spanish Approach for Better Stratification with Classical Tools

Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients

P728: GENE EXPRESSION PROFILE REVELS T‐LYMPHOCYTES ACTIVATION THROUGH CELL CYCLE PROGRESSION AND MITOCHONDRIAL METABOLISM REGULATION IN MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) AFTER LENALIDOMIDE TREATMENT

DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia

CD34?+ cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation

Mutational and Clonal Dynamics During Progression from MDS to SAML by Whole-Exome and Targeted-Deep Sequencing

Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation

Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence

Suchergebnisse filtern